Adagio Medical Holdings Inc (ADGM)
2.86
-0.56
(-16.37%)
USD |
NASDAQ |
Sep 27, 16:00
2.87
+0.01
(+0.35%)
After-Hours: 20:00
Adagio Medical Holdings Cash from Financing (TTM): -1.934M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.934M |
| December 31, 2023 | -113.02M |
| September 30, 2023 | -113.37M |
| June 30, 2023 | -113.81M |
| March 31, 2023 | -114.35M |
| Date | Value |
|---|---|
| December 31, 2022 | 0.075M |
| September 30, 2022 | -0.043M |
| June 30, 2022 | -0.043M |
| March 31, 2022 | -0.043M |
| December 31, 2021 | 151.07M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-114.35M
Minimum
Mar 2023
151.07M
Maximum
Dec 2021
-30.55M
Average
-0.9884M
Median
Cash from Financing (TTM) Benchmarks
| Standard BioTools Inc | -50.26M |
| Ainos Inc | 12.52M |
| Zomedica Corp | -- |
| LENSAR Inc | -0.06M |
| Intelligent Bio Solutions Inc | -- |